156 related articles for article (PubMed ID: 17722964)
1. Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Sander Florman.
Florman S
Drugs; 2007; 67(13):1944. PubMed ID: 17722964
[No Abstract] [Full Text] [Related]
2. Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Helio Tedesco Silva Jr.
Silva HT
Drugs; 2007; 67(13):1944-5. PubMed ID: 17722963
[No Abstract] [Full Text] [Related]
3. Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients.
Cross SA; Perry CM
Drugs; 2007; 67(13):1931-43. PubMed ID: 17722962
[TBL] [Abstract][Full Text] [Related]
4. Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.
Grinyó JM; Petruzzelli S
Expert Rev Clin Immunol; 2014 Dec; 10(12):1567-79. PubMed ID: 25407098
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients.
Garnock-Jones KP
Drugs; 2015 Feb; 75(3):309-20. PubMed ID: 25613762
[TBL] [Abstract][Full Text] [Related]
6. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
7. Extended-release tacrolimus: a review of its use in de novo kidney transplantation.
McCormack PL
Drugs; 2014 Nov; 74(17):2053-64. PubMed ID: 25352392
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation.
Rubik J; Debray D; Iserin F; Vondrak K; Sellier-Leclerc AL; Kelly D; Czubkowski P; Webb NJA; Riva S; D'Antiga L; Marks SD; Rivet C; Tönshoff B; Kazeem G; Undre N
Pediatr Transplant; 2019 Jun; 23(4):e13391. PubMed ID: 30932313
[TBL] [Abstract][Full Text] [Related]
9. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
10. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
[TBL] [Abstract][Full Text] [Related]
11. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR
Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
13. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.
Tanzi MG; Undre N; Keirns J; Fitzsimmons WE; Brown M; First MR
Clin Transplant; 2016 Aug; 30(8):901-11. PubMed ID: 27220013
[TBL] [Abstract][Full Text] [Related]
16. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
Tsuchiya T; Ishida H; Tanabe T; Shimizu T; Honda K; Omoto K; Tanabe K
Transplantation; 2013 Jul; 96(2):198-204. PubMed ID: 23792649
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic model and Bayesian estimator for 2 tacrolimus formulations in adult liver transplant patients.
Riff C; Debord J; Monchaud C; Marquet P; Woillard JB
Br J Clin Pharmacol; 2019 Aug; 85(8):1740-1750. PubMed ID: 30973981
[TBL] [Abstract][Full Text] [Related]
19. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis for optimizing the modified release tacrolimus (Advagraf) after kidney transplantation: A prospective randomized trial.
Bakr MA; Nagib AM; Donia AF; Denewar AA; Abu-Elmagd MM; Abbas MH; Abdel-Rahman AM; Mashaly ME; Elsaftawy MM; Ghoneim MA
Saudi J Kidney Dis Transpl; 2018; 29(6):1267-1273. PubMed ID: 30588956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
